Today is Wednesday, Nov. 14, 2018

Department of Internal Medicine

Hematology & Oncology

Director's Welcome

I would like to welcome you to the web pages of the Division of Hematology Oncology and hope that you will find the information on our site helpful and informative.

It is my privilege to lead a group of outstanding physicians, clinical investigators and researchers dedicated to the tripartite mission of the College of Medicine: education, research and patient care. The division strives to achieve these goals by:

  • Providing cutting-edge treatment to about 3500 new patients a year;
  • Providing experience-driven education to our trainees
  • Testing new drugs in our Experimental Therapeutics Program
  • Revealing the mechanisms that govern cancer in our laboratories

I anticipate that we will continue to increase the pace of our discoveries and expand our clinical services and educational activities, by adding several additional faculty members to our ranks. Areas of emphasis will be the expansion of our Experimental Therapeutic Program, the Bone Marrow Transplant Program and the divisional research laboratories. I expect that these efforts will continue to provide the framework for the development of cutting edge cancer treatments. Our faculty and staff have a close partnership with the University of Cincinnati Cancer Institute, The Cincinnati Cancer Center and the Cincinnati Cancer Consortium. This partnership allows them to work together in multidisciplinary clinics, actively participate in disease focused tumor boards and interact with research scientists. This combination of efforts is instrumental for the continued growth of our clinical and research cancer programs, and the pace of discovery and the quality of patient care. 

I will summarize below the key components of our Division, which will be expanded upon in the next pages.

  1. Clinical activities: The division consists of 16 clinical faculty members and 17 advanced practice providers which staff the inpatient and outpatient units of the University of Cincinnati Medical Center, Cincinnati VA Medical Center, UC Cancer Institute and the West Chester Medical Center. Each faculty member has a cancer specific focus, is a member of disease-oriented teams, and regularly attends disease specific tumor boards.

     

  2. Laboratory research: The division has 7 Research faculty dedicated to translational cancer research.Research interest include oncogene-dependent cell signaling, cancer metabolism, cell cycle and DNA repair, mTOR signaling, proteasome biology in multiple myeloma, immunotherapy of lung and head and neck cancer, nanoparticle therapeutics, the role of tissue factors in blood coagulation and cancer.

     

  3. Fellowship Program: The division supports 12 fellows. In addition to the traditional fellowship training in Hematology and Oncology, we also offer two highly specialized fellowships in Experimental Therapeutics and in Hematological Malignancies and Bone Marrow Transplantation. Fellows spend their clinical training at the University of Cincinnati Medical Center, Cincinnati VA Medical Center and the UC Cancer Institute. We offer protected time for ample research opportunities in the Divisional Experimental Therapeutic Program and research labs. Fellows have access to additional research and training opportunities in immunobiology, laboratory medicine, transfusion medicine, cell mediated therapy and cancer biology at the University of Cincinnati Medical College, the Hoxworth Blood Center or the Cincinnati Children’s Hospital Medical Center.

The division is undergoing a significant expansion to increase our academic and clinical missions. For instance, the UC Cancer Institute at West Chester Hospital is undergoing a doubling of its footprint, which will allow a significant expansion of our clinical services. Significant recruitment of clinical investigators and research faculty is ongoing to increase the size and scope of our Experimental Therapeutic program and divisional labs and to further develop our research portfolio in immunotherapy, cancer metabolism, drug resistance and functional genomics. These activities will increase the quality of patient care, educational programs and service we deliver to the community.

We invite you to revisit this site on a regular basis to learn more about what we are doing to become one of the elite divisions of Hematology and Oncology in the country.

Sincerely,

Pier Paolo Scaglioni, MD
The Herbert F. Koch Professor of Medicine
Director, Division of Hematology and Oncology
University of Cincinnati College of Medicine

 

CARE/Crawley Building

More Information

Academic Office:
University of Cincinnati | Division of Hematology Oncology
Vontz Center for Molecular Studies
3125 Eden Avenue, ML 0562
Cincinnati, OH 45267-0562
Phone: 513-558-2115
Fax: 513-558-2125
Email: Hematology Oncology

Division Director:
Pier Paolo Scaglioni, MD

Business Administrator:
Barb Kilgus
513-558-2184
Hematology Oncology